Dr. Howard Berger leads the division of Maternal Fetal Medicine and Obstetric Ultrasound at St. Michael’s Hospital and is a Professor in the University of Toronto Department of Obstetrics and Gynecology.  He is PI of the Diabetes, Obesity and Hypertension in Pregnancy Research Network (DOH-Net) Research focuses include Diabetes and adiposity in pregnancy, prenatal ultrasound and prenatal screening.


Recent Publications

  1. Jegathesan, T, Campbell, DM, Ray, JG, Shah, V, Berger, H, Hayeems, RZ et al.. Transcutaneous versus Total Serum Bilirubin Measurements in Preterm Infants. Neonatology. 2021; :1-11. doi: 10.1159/000516648. PubMed PMID:34139689 .
  2. Shinar, S, Melamed, N, Abdulaziz, KE, Ray, JG, Riddell, C, Barrett, J et al.. Changes in rate of preterm birth and adverse pregnancy outcomes attributed to preeclampsia after introduction of a refined definition of preeclampsia: a population-based study. Acta Obstet Gynecol Scand. 2021; :. doi: 10.1111/aogs.14199. PubMed PMID:34043808 .
  3. Lipworth, H, Melamed, N, Berger, H, Geary, M, McDonald, SD, Murray-Davis, B et al.. Maternal weight gain and pregnancy outcomes in twin gestations. Am J Obstet Gynecol. 2021; :. doi: 10.1016/j.ajog.2021.04.260. PubMed PMID:33984302 .
  4. Ashwal, E, Berger, H, Hiersch, L, Yoon, EW, Zaltz, A, Shah, B et al.. Gestational diabetes and fetal growth in twin compared with singleton pregnancies. Am J Obstet Gynecol. 2021; :. doi: 10.1016/j.ajog.2021.04.225. PubMed PMID:33872592 .
  5. Pinto, L, Bapat, P, de Lima Moreira, F, Lubetsky, A, de Carvalho Cavalli, R, Berger, H et al.. Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model. Pharm Res. 2021;38 (4):647-655. doi: 10.1007/s11095-021-03035-7. PubMed PMID:33825113 .
  6. Ashwal, E, Hiersch, L, Berger, H, Aviram, A, Zaltz, A, Kingdom, J et al.. Pathologic Basis for the Definition of Discordant Growth in Dichorionic Twins. Fetal Diagn Ther. 2021;48 (4):279-287. doi: 10.1159/000514328. PubMed PMID:33780952 .
  7. Read, SH, Rosella, LC, Berger, H, Feig, DS, Fleming, K, Kaul, P et al.. Diabetes after pregnancy: a study protocol for the derivation and validation of a risk prediction model for 5-year risk of diabetes following pregnancy. Diagn Progn Res. 2021;5 (1):5. doi: 10.1186/s41512-021-00095-6. PubMed PMID:33678196 PubMed Central PMC7938478.
  8. Dennis, CL, Marini, F, Dick, JA, Atkinson, S, Barrett, J, Bell, R et al.. Protocol for a randomised trial evaluating a preconception-early childhood telephone-based intervention with tailored e-health resources for women and their partners to optimise growth and development among children in Canada: a Healthy Life Trajectory Initiative (HeLTI Canada). BMJ Open. 2021;11 (2):e046311. doi: 10.1136/bmjopen-2020-046311. PubMed PMID:33568380 PubMed Central PMC7878148.
  9. Read, SH, Rosella, LC, Berger, H, Feig, DS, Fleming, K, Ray, JG et al.. BMI and risk of gestational diabetes among women of South Asian and Chinese ethnicity: a population-based study. Diabetologia. 2021;64 (4):805-813. doi: 10.1007/s00125-020-05356-5. PubMed PMID:33486538 .
  10. Davidson, AJF, Park, AL, Berger, H, Aoyama, K, Harel, Z, Cohen, E et al.. Association of Improved Periconception Hemoglobin A1c With Pregnancy Outcomes in Women With Diabetes. JAMA Netw Open. 2020;3 (12):e2030207. doi: 10.1001/jamanetworkopen.2020.30207. PubMed PMID:33355674 PubMed Central PMC7758806.
Search PubMed

Affiliations & Other Activities

  • Head, Maternal Fetal Medicine and Obstetric Ultrasound, Obstetrics and Gynecology, St. Michael’s Hospital
  • Deputy Chief, Obstetrics, St. Michael’s Hospital
  • Program Director: Advanced High Risk Obstetrics, Obstetrics and Gynecology, St. Michael’s Hospital and University of Toronto
  • Associate Professor, Department of Obstetrics and Gynecology, University of Toronto